Bridging the Data Divide in Nevada: A Repeated Cross-Sectional Study of Birth Certificate and Medicaid Billing Discrepancies in Gestational Substance Exposure
Kyra Morgan, Kavita Batra, Stephanie Woodard, Erika Ryst, Paul Devereux, Wei Yang

TL;DR
This study finds significant discrepancies in reporting gestational substance exposure between birth certificates and Medicaid data in Nevada, highlighting the need for better data integration to improve early detection and equity.
Contribution
The study introduces a novel analysis of gestational substance exposure reporting discrepancies using Medicaid and birth certificate data in Nevada.
Findings
The discordance rate in GES reporting was 95.09 per 1000 live births.
Higher discordance was observed among White non-Hispanic mothers and those in rural or low-income areas.
Hospital-level factors also contributed to variation in reporting discrepancies.
Abstract
Background/Objectives: Gestational exposure to substances (GES) is associated with adverse developmental outcomes. Early identification is limited by reliance on self-reported data. This study assessed the incidence and predictors of discordance in GES reporting between birth certificates and Medicaid claims among Medicaid-covered births in Nevada from 2022 to 2024. Methods: A statewide, hospital-clustered, cross-sectional analysis was conducted using linked Medicaid billing and birth record data. Discordance was defined as GES identified in one source but not the other. Incidence per 1000 live births was stratified by demographic characteristics. Multilevel logistic regression assessed patient- and hospital-level predictors, with random hospital intercepts. Results: Among 50,394 live births, the discordance rate was 95.09 per 1000 (95% Confidence Interval: 92.5–97.7). Substantial…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPrenatal Substance Exposure Effects · Pregnancy and Medication Impact · Effects and risks of endocrine disrupting chemicals
